Notable insider buying and selling activity across public companies.
Tracking and analysis of reported insider transactions, including executive and director buying or selling. Insider activity can offer insight into internal confidence, valuation perceptions, and potential inflection points.
13,303 total articles
Alignment Healthcare Chief Executive Officer John E. Kao sold a total of 337,900 shares of common stock across multiple transactions on April 10 and April 13, 2026, raising roughly $6.16 million. The disposals occurred while shares traded near recent highs and followed strong quarterly results and analyst reaffirmations. The trades were made under …
Qualcomm EVP, CFO and COO Akash J. Palkhiwala sold 2,500 shares of company stock on April 13, 2026, under a pre-arranged 10b5-1 trading plan for about $325,854. The transactions, executed in two tranches, fetched prices between $130.1206 and $131.1652. After the sales, Palkhiwala directly owns 30,684 shares, including 85 shares acquired through the…
NeonC Technologies Holdings, Inc. (NASDAQ:NTHI) reported an insider purchase by Chief Accounting Officer David Suh, Jr., who acquired 200 shares at $5.00 per share on April 9, 2026. The company has also disclosed prior equity grants to Suh, a $16 million private placement, resolution of a legal dispute with Fox Infused, LLC, a leadership appointmen…
Carlson Capital, L.P., a roughly 10% holder of Runway Growth Finance Corp., disposed of 560,105 common shares on April 9, 2026, at $6.59 per share for about $3.69 million. The sale leaves Carlson Capital with 3,885,000 shares. The move coincides with Runway trading near a 52-week low and with the company reporting softer quarterly results and compl…
BridgeBio Pharma CEO Neil Kumar sold a series of holdings in the company’s common stock on April 9 and April 10 under a pre-arranged Rule 10b5-1 trading plan. The transactions, executed indirectly through trusts where Kumar is co-trustee, total $5,968,780. Kumar continues to retain substantial direct and indirect ownership, and the company remains …
Hippo Holdings Chief Executive Richard McCathron sold 5,000 shares of the company on April 9, 2026, generating $130,250 in proceeds. The transaction was executed under a Rule 10b5-1 plan. Hippo recently posted robust fourth-quarter 2025 results, highlighted by higher gross written premium and a broader insurance mix, and unveiled an AI-driven claim…
Liquidia Corp's CEO, Roger Jeffs, sold 25,000 shares on April 9, 2026, for approximately $1.003 million under a prearranged 10b5-1 plan. The transaction occurred after a year of large share gains and follows a quarter in which Yutrepia revenue rose sharply while earnings per share missed expectations. Analysts maintained constructive ratings and ra…
Liquidia Corp's CFO and COO, Michael Kaseta, sold 133,789 shares of common stock on April 9, 2026, for about $5.3 million and exercised options to acquire the same number of shares at low strike prices. The transactions followed a quarter of strong revenue from the Yutrepia launch and guidance that projects revenue above $1 billion in 2027. Analyst…
Susan M. Byrne, Director Emerita of Westwood Holdings Group Inc (NYSE: WHG), sold 2,901 shares between April 9 and April 13, 2026, realizing roughly $47,148. The transactions were executed under a Rule 10b5-1 trading plan adopted April 1, 2026. Westwood reported revenue and net income gains in Q4 2025, and the stock trades near the upper end of Byr…
David A. Duffield, who owns roughly 10% of Workday, sold 117,100 shares of Class A stock on April 9, 2026, under a Rule 10b5-1 plan for about $12 million. The company reported Q4 FY2026 results that met revenue guidance and beat earnings, while several analysts reduced price targets. Duffield also converted 107,500 Class B shares into Class A stock…
RA Capital Management and related entities acquired a total of $1.6 million of Adicet Bio (NASDAQ: ACET) common stock across three transactions executed February 18-20, 2026. The buys, reported under transaction code "P," totaled 223,596 shares and occurred as the stock traded close to its 52-week low. Recent analyst activity shows mixed adjustment…
Mat Ishbia, President and CEO of UWM Holdings Corp (NASDAQ:UWMC), and SFS Holding Corp., a 10% owner, sold a combined 3,001,722 shares of Class A common stock across three transactions executed under a 10b5-1 plan. The disposals totaled about $11.28 million and leave SFS Holding with 4,324,691 shares and Ishbia with 408,131 shares directly. The mov…
Fluor Corporation sold 13,500,000 shares of NuScale Power Class A common stock on April 9, 2026, realizing $162.9 million at $12.0665 per share. The transaction reduces Fluor's direct holding to 26,436,472 NuScale shares and was executed under a previously disclosed arrangement. The move coincides with a significant decline in NuScale's share price…
Tom L. Ward, a director of Mach Natural Resources LP (MNR), increased his exposure to the partnership on April 13, 2026, through two purchases that together totaled 153,256 common units and $1,999,990. The transactions, recorded on a Form 4 filing with the SEC, came as the unit price traded below the $13.05 purchase level and following a week in wh…
Broadcom director Gayla J. Delly sold 1,000 shares of the company's common stock on April 9, 2026, for $358.31 apiece, a transaction valued at $358,310, according to a Form 4 filing with the SEC. The sale comes as Broadcom shares have climbed more than 105% over the past year and after the company disclosed a multi-year extension with Google and ot…
Edward J. Hoffman, senior executive and general counsel at Radian Group (RDN), sold 1,991 shares on April 10, 2026, under a 10b5-1 plan. The company also reported Q4 2025 earnings that modestly exceeded expectations and amended a repurchase agreement that lowers the subsidiary borrowing cap to $25 million for residential mortgage loan acquisitions.
A spouse of major Ginkgo Bioworks shareholder Canton Barry sold 124,727 Class A shares on April 10, 2026, to satisfy tax withholding obligations tied to the vesting of performance-based restricted stock units. The transaction followed the April 9, 2026 vesting of 251,786 PSUs. Ginkgo reported improvements in financial management and reduced operati…
ServiceTitan Chief Accounting Officer Michele O’Connor executed a sale of 5,000 Class A shares on April 9, 2026, for $58.93 per share, netting $294,650. The transaction, disclosed in a Form 4 filed with the SEC and signed on her behalf on April 13, 2026, leaves O’Connor with 79,416.5 directly held shares. The move occurs while the stock trades clos…
Brett Alan Cope, President and CEO of Powell Industries INC (NASDAQ:POWL), sold 4,440 shares on April 9, 2026 under a Rule 10b5-1 plan, generating roughly $1.04 million. The sale occurred as the stock traded close to its 52-week high after a 302% return over the past year. Powell reported fiscal 2026 first-quarter EPS that beat estimates and announ…
Meredith Cook, Senior Vice President, General Counsel and Secretary of ANI Pharmaceuticals (ANIP), sold 500 shares on April 13, 2026, for $77.95 apiece, netting $38,975. The trade was carried out under a Rule 10b5-1 plan adopted on September 15, 2025. ANI reported fourth-quarter 2025 EPS of $2.33 and revenue of $247.1 million, both above consensus,…
Braze, Inc. general counsel Susan Wiseman sold 35,000 shares of Class A common stock on April 9, 2026, for $710,150, according to an SEC Form 4 filing. The transaction occurred as the share price has fallen sharply year-to-date; analysts have issued divergent price target changes even as firms highlighted solid bookings and revenue growth.
Exzeo Group Chief Executive Officer Paresh Patel acquired 2,000 shares of the company's common stock on April 10, 2026, paying $15.38 per share for a total of $30,760. After the trade Patel directly owns 1,608,013 shares and retains options to buy 5,000,000 additional shares under an October 1, 2021 grant. The transaction comes as Exzeo reported fo…
Guidewire Software Chief Executive Michael George Rosenbaum sold 1,200 shares on April 13, 2026, for $118.77 per share, generating $142,524. The sale was carried out automatically under a 10b5-1 plan adopted October 14, 2025. Guidewire also reported fiscal second-quarter results that exceeded expectations across revenue, annual recurring revenue (A…
Martine Rothblatt, Chairperson and CEO of United Therapeutics (UTHR), sold roughly $5.4 million of company stock on April 10, 2026, while also exercising stock options. The transactions were carried out under a 10b5-1 trading plan put in place in November 2025. The moves come as the stock trades close to its 52-week high and after a year of signifi…
Village Super Market Inc.'s CFO and Treasurer, John L. Van Orden, reported the sale of 8,000 Class A shares for $351,032 in a Form 4 filing. The company recently declared a quarterly cash dividend and continues to litigate against Wakefern Food Corp., where counterclaims and a third-party complaint have been filed.
